Will Morton[email protected]Digital X-RayDEXA reveals tea consumption supports bone healthModerate-frequency tea consumption was associated with better bone mineral status and more favorable longitudinal changes.August 12, 2026CTStepped reminders boost CT lung cancer screeningTrial findings directly address the current lack of effective lung cancer screening interventions.August 11, 2026Practice ManagementPatient-friendly radiology reports improve family comprehensionTerminology in radiology reports can be difficult for patients and families to comprehend.August 5, 2026InterventionalCT-selected thrombectomy shows 1-year benefit in large-core strokeNotably, the TESLA trial used a noncontrast CT (NCCT)-alone patient selection protocol.August 3, 2026Molecular ImagingPET/MRI detects arterial inflammation in prostate cancer patientsAndrogen deprivation therapy (ADT) is widely used in advanced prostate cancer, yet is associated with increased cardiovascular events such as stroke and heart attacks.July 31, 2026CTNongated CT scans can predict heart disease riskSubjects with moderate and severe CAC scores on nongated CT had significantly higher risk of coronary heart disease risk.July 30, 2026CTCT radiation doses have fallen sharply over past decadeThe largest reductions appeared in chest examinations with contrast material, where diagnostic reference levels fell 31%.July 28, 2026Molecular ImagingSPECT/CT viable over PET/CT for high-risk prostate cancer stagingConsidering its broader accessibility, Tc-99m MIP-1404 CZT SPECT/CT may represent a practical alternative for primary staging.July 24, 2026Editor's NoteAuntMinnie.com Molecular Imaging InsiderIn this edition of the Molecular Imaging Insider, we’ve highlighted a study showing that Lutetium-177 PSMA-617 spots early signs of benefit in men with metastatic hormone-sensitive prostate cancer.July 21, 2026Nuclear MedicineLutetium-177 PSMA-617 shows promise in earlier-stage prostate cancerAcross 14 studies, PSA50 response rates (the number of patients with at least a 50% drop in PSA) ranged from 44% to 100%.July 21, 2026Previous PagePage 2 of 57Next PageTop StoriesMRIMRI-based biomarker tool can predict progression to dementiaThe tool measures gray matter shrinkage in the brain, predicting when mild cognitive impairment progresses to dementia.CTIs nitroglycerin necessary prior to photon-counting CT?Molecular ImagingPET outperforms CT in ovarian cancerUltrasoundAdvanced ultrasound techniques improve soft tissue tumor evaluationSponsor ContentNominations Are Open — 2026 Minnies